Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neutrophil function and survival with tocilizumab in active rheumatoid arthritis
2010-018331-18Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Primary endpoints: Neutrophil survival and function, Safety (adverse events and laboratory abnormalities) and 1 more. Started Mar 2010; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-018331-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018331-18.